Erbi's differentiated 2 ml micro-bioreactor platform technology, Breez ™, enables rapid lab testing for bioprocessing scale up Allows MilliporeSigma to offer full range of bioreactors, from 2ml to ...

Sunflower Therapeutics (Sunflower), a public benefit corporation transforming global access to protein manufacturing capacity for diverse applications, announced today its first distribution agreement ...

Developing a new therapeutic molecule is a complex and expensive process with a high risk of failure at each step. Research suggests that aggregate costs per commercialized drug (including failures) ...

BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announced that National Resilience, Inc.

WALTHAM, Mass., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Sartorius and Repligen Corporation (NASDAQ:RGEN) today announced the launch of an integrated bioreactor system that incorporates Repligen XCell® ATF ...

The demand for producing therapeutic recombinant proteins is generating a renewed interest in perfusion cell culture technologies, leading to the development of cell culture media that can support ...

Daisy Petal™ systems installed in GMP space to enable perfusion fermentation at SIIPL, enabling faster, higher-yield protein production in a compact, user-friendly platform MEDFORD, Mass. & PUNE, ...

Achieving high cell densities in long-term cultures is often a challenge facing bioprocessing manufacturers, and one that requires the support of optimal media. FUJIFILM Irvine Scientific recently sat ...

The intensification of upstream bioprocessing sounds daring, as though it were equivalent to flooring a car’s accelerator pedal and pushing the tachometer into the red zone. But with the right ...

The biopharmaceutical industry is expanding rapidly, driven by an increasing demand for complex biomedicines. Today, manufacturing biomolecules presents unique challenges, like cost pressure and ...